{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "AUD", "marketState": "PRE", "exchangeTimezoneShortName": "AEST", "gmtOffSetMilliseconds": 36000000, "esgPopulated": false, "regularMarketChangePercent": 5.6149745, "regularMarketPrice": 3.95, "exchange": "ASX", "shortName": "M PHARMA FPO", "longName": "Mayne Pharma Group Limited", "messageBoardId": "finmb_28606250", "exchangeTimezoneName": "Australia/Sydney", "market": "au_market", "regularMarketTime": 1683785404, "regularMarketDayHigh": 3.96, "regularMarketDayRange": "3.74 - 3.96", "regularMarketDayLow": 3.74, "regularMarketVolume": 368016, "regularMarketPreviousClose": 3.74, "bid": 3.93, "ask": 3.95, "bidSize": 0, "askSize": 0, "fullExchangeName": "ASX", "financialCurrency": "AUD", "regularMarketOpen": 3.76, "averageDailyVolume3Month": 332621, "averageDailyVolume10Day": 278807, "fiftyTwoWeekLowChange": 1.27, "fiftyTwoWeekLowChangePercent": 0.4738806, "fiftyTwoWeekRange": "2.68 - 8.5", "fiftyTwoWeekHighChange": -4.55, "fiftyTwoWeekHighChangePercent": -0.5352941, "fiftyTwoWeekLow": 2.68, "fiftyTwoWeekHigh": 8.5, "earningsTimestamp": 1677535200, "earningsTimestampStart": 1677535200, "earningsTimestampEnd": 1677535200, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -3.77, "epsForward": -0.55, "epsCurrentYear": -1.27, "priceEpsCurrentYear": -3.1102364, "sharesOutstanding": 85074304, "bookValue": 9.046, "fiftyDayAverage": 3.879, "fiftyDayAverageChange": 0.0710001, "fiftyDayAverageChangePercent": 0.018303713, "twoHundredDayAverage": 4.7214, "twoHundredDayAverageChange": -0.77139974, "twoHundredDayAverageChangePercent": -0.16338369, "marketCap": 369288288, "forwardPE": -7.181818, "priceToBook": 0.4366571, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "averageAnalystRating": "3.0 - Hold", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1183075200000, "priceHint": 4, "regularMarketChange": 0.21000004, "symbol": "MYX.AX"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "1538 Main North Road", "city": "Salisbury South", "state": "SA", "zip": "5106", "country": "Australia", "phone": "61 8 8209 2666", "fax": "61 8 8281 0284", "website": "https://www.maynepharma.com", "industry": "Drug Manufacturers\u2014General", "industryDisp": "Drug Manufacturers\u2014General", "sector": "Healthcare", "longBusinessSummary": "Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe and Asia. The company operates through four segments: Metrics Contract Services, International, Branded Products, and Portfolio Products. It provides oral drug delivery systems; and contract pharmaceutical development, manufacturing, and analytical services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Shawn Patrick O'Brien B.Sc", "title": "CEO, MD & Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Aaron  Gray", "title": "Chief Financial Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Kimberly  Parker J.D.", "title": "Exec. VP & Gen. Counsel", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Brant  Schofield", "age": 56, "title": "Exec. VP of Corp. Devel.", "yearBorn": 1966, "fiscalYear": 2019, "totalPay": {"raw": 1037502, "fmt": "1.04M", "longFmt": "1,037,502"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Erinn  Nathaniel", "title": "Director of Global HR", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Daniel  Moore", "title": "Exec. VP of Commercial", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Hemanshu N. Pandya", "title": "Sr. VP & Head of Generic Product Division", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Brenton  Walter", "title": "Financial Controller", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Laura  Loftus", "title": "Associate Gen. Counsel & Company Sec.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 6, "boardRisk": 2, "compensationRisk": 9, "shareHolderRightsRisk": 7, "overallRisk": 5, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1577750400, "maxAge": 86400}}], "error": null}}